Paris - One of the most promising areas of research for treatment of cutaneous T-cell lymphoma is the development of therapeutic vaccines, according to Wolfram Sterry, M.D., who presented an overview of vaccination therapies for treatment of CTCL here at the World Congress of Dermatology.
